ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,271.31
-0.12%
Dow Jones
38,481.52
-0.53%
US Dollar vs MXN
17.54298
3.34%
Brent Oil
78.445
-2.92%
Bitcoin
69,157.26
2.08%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Bausch plus Lomb Corporation (BLCO)

  7. Bausch plus Lomb Corporation (BLCO) Noticias

BLCO Bausch plus Lomb Corporation

15.33
-0.01 (-0.07%)
Última actualización: 09:57:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bausch plus Lomb Corporation BLCO NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.01 -0.07% 15.33 09:57:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.30 15.25 15.55 15.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202406:00BWBausch + Lomb Launches Blink™ NutriTears® Clinically Proven..
29/5/202415:44EDGAR2Form 8-K - Current report
29/5/202415:30BWBausch + Lomb Announces 2024 Annual Meeting of Shareholder..
28/5/202408:00BWBausch + Lomb Announces Presentation of New Scientific Data..
28/5/202405:59BWBausch + Lomb Receives Health Canada Approval for enVista®..
07/5/202408:09IHMARKETNEWSFutures Pointing To Roughly Flat Open On Wall Street
06/5/202415:34IHMARKETNEWSU.S. Stocks See Further Upside Amid Renewed Interest Rate..
01/5/202405:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202406:00BWBausch + Lomb Announces Presentation of New Data at the..
25/4/202407:30BWBausch + Lomb Announces Statistically Significant Results..
18/4/202406:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15/4/202411:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/3/202406:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202407:12EDGAR2Form 8-K - Current report
28/2/202407:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21/2/202406:00EDGAR2Form 8-K - Current report
21/2/202406:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21/2/202405:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
05/2/202411:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08/1/202405:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
03/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15/11/202305:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
13/11/202315:47EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202316:00EDGAR2Form 8-K/A - Current report: [Amend]
01/11/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202306:02EDGAR2Form 8-K - Current report
01/11/202305:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26/10/202305:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
16/10/202311:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04/10/202305:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
03/10/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:24EDGAR2Form 8-K - Current report
29/9/202309:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26/9/202305:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20/9/202305:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
14/9/202316:26EDGAR2Form 8-K - Current report
14/9/202316:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12/9/202305:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11/9/202306:22EDGAR2Form 8-K - Current report
11/9/202306:07BWBausch + Lomb Announces Launch of Proposed Financing for..
06/9/202316:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
06/9/202316:28EDGAR2Form 8-K - Current report

Su Consulta Reciente

NYSE
BLCO
Bausch plus Lomb
EU
HMES
HSBC ETFs
NASDAQI
HAZ
Settle ISE British Pound...
BIT
O8JQC9
Morgan Stanley BV
TSX
AGR.UN
Sustainable Agriculture ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados